Matthias Kleinz, EVP of Translational Sciences at UPMC Enterprises at HLTH2025 with Ian Khan
At HLTH 2025, Ian Khan sits down with Matthias Kleinz of UPMC Enterprises to discuss how one of America鈥檚 leading health systems is accelerating healthcare innovation. Matthias shares insights on startups, translation of research into real-world therapies, AI鈥檚 role in healthcare, and why adoption of cutting-edge tech in health systems is slower than the hype. Matthias Kleinz, DVM, PhD, serves as Executive Vice President of Translational Sciences at UPMC Enterprises, where he oversees the commercialization of life-science and health-tech breakthroughs. With a background in veterinary medicine and pharmacology (University of Cambridge), and nearly a decade in consulting, Matthias joined UPMC in 2017 to bridge academic research and healthcare deployment. 馃敆 Stay Connected: Buy a Copy of My New Book UNDUSRUPTED https://amzn.to/4g5gjH9 Visit my website: www.iankhan.com Follow me on Twitter: https://twitter.com/IanKhanFuturist Follow me on LinkedIn: https://www.linkedin.com/in/iankhanfuturist Follow me on Facebook: https://www.facebook.com/iankhanfuturist